Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma. (Q47826637)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

title

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Vanna Chiarion Sileni

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Piotr Rutkowski

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

John Wagstaff

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Pier Francesco Ferrucci

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Ivan Marquez-Rodas

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Grant McArthur

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Georgina V. Long

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Jonathan Cebon

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

1

Jedd D Wolchok

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Paolo Antonio Ascierto

23

object named as

Paolo A Ascierto

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

32

F Stephen Hodi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

33

James Larkin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

12

Reinhard Dummer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

15

John Haanen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

9

Dirk Schadendorf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

author name string

Rene Gonzalez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Jean-Jacques Grob

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

C Lance Cowey

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Christopher D Lao

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Michael Smylie

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Andrew Hill

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

David Hogg

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Matteo S Carlino

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Oliver Bechter

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Michele Maio

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Celeste Lebbé

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Jeffrey Sosman

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Michael A Postow

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Margaret K Callahan

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Dana Walker

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Linda Rollin

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Rafia Bhore

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

language of work or name

English

0 references

publication date

11 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

The New England Journal of Medicine

29 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

volume

377

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

page(s)

1345-1356

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

issue

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study

29 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5706778

Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5706778

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5706778

Nivolumab and ipilimumab versus ipilimumab in untreated melanoma

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5706778

Pembrolizumab versus Ipilimumab in Advanced Melanoma

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5706778

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5706778

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5706778

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5706778

Measuring diagnostic and predictive accuracy in disease management: an introduction to receiver operating characteristic (ROC) analysis

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5706778

Time-dependent ROC curves for censored survival data and a diagnostic marker

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5706778

16 June 2018

Identifiers

DOI

10.1056/NEJMOA1709684

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28889792%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

1 reference